COVID-19 and stem cells therapy

Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors https://doi.org/10.1186/s13287-019-1156-6 Abstract Background Immunoregulatory capacity of mesenchymal stem cells (MSC) is triggered by the inflammatory environment, which changes during tissue repair. Macrophages are essential in mediating the inflammatory response after injury and can adopt a range of functional Read more…

Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee

Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee   BACKGROUND: The intra-articular injection of mesenchymal stem cells (MSCs) into the knee has shown a potential for the treatment of generalized cartilage loss in osteoarthritis (OA). However, there have been few midterm reports with clinical Read more…

Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity

Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity Yong-Beom Park, MD, PhD, Chul-Won Ha, MD, PhD‖, Ji Heon Rhim,..   Background: Following successful preclinical studies, stem cell therapy is emerging as a candidate Read more…

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells   Prolonged life expectancy, life style and environmental changes have caused a changing disease pattern in developed countries towards an increase of degenerative and autoimmune diseases. Stem cells have become Read more…

Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy

Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy Brief Summary:This clinical trial assessed the safety of human umbilical cord mesenchymal stem cell therapy in 15 patients with diabetic nephropathy. Fifteen subjects received umbilical cord mesenchymal stem cell therapy 3 times. Approximately 1 × 106/kg of human umbilical cord mesenchymal stem cells Read more…

stem cell therapy